These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6892270)

  • 1. Differential inhibition by adenosine or by prostaglandin E1 of human platelet aggregation induced by adenosine 5'-O-(1-thiodiphosphate) and adenosine 5'-O-(2-thiodiphosphate).
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1982 Feb; 75(2):257-9. PubMed ID: 6892270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial agonist behaviour of adenosine 5'-O-(2-thiodiphosphate) on human platelets.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1981 Jun; 73(2):405-8. PubMed ID: 7236992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of RP and SP diastereoisomers of adenosine 5'-O-(1-thiodiphosphate) on human platelets.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1981 Jun; 73(2):409-12. PubMed ID: 7236993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1982 May; 76(1):221-7. PubMed ID: 6282375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive inhibition by adenosine 5'-triphosphate of the actions on human platelets of 2-chloroadenosine 5'-diphosphate, 2-azidoadenosine 5'-diphosphate and 2-methylthioadenosine 5'-diphosphate.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1982 Oct; 77(2):329-33. PubMed ID: 7139191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.
    Hall DA; Hourani SM
    Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.
    Park HS; Hourani SM
    Br J Pharmacol; 1999 Jul; 127(6):1359-66. PubMed ID: 10455285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: evidence for covalent modification of cysteine and lysine residues.
    Puri RN; Colman RW
    Arch Biochem Biophys; 1991 May; 286(2):419-27. PubMed ID: 1910292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between dipyridamole and prostaglandin E1 with ADP-induced aggregation of rat platelet in whole blood.
    Touqui L; Hatmi M; Vargaftig BB
    Thromb Haemost; 1984 Jul; 51(3):410. PubMed ID: 6541815
    [No Abstract]   [Full Text] [Related]  

  • 10. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.
    Macfarlane DE; Srivastava PC; Mills DC
    J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADP induces desensitisation of equine platelet aggregation responses: studies using ADP beta S, a stable analogue of ADP.
    Poole AW; Heath MF; Evans RJ
    Res Vet Sci; 1993 Mar; 54(2):235-43. PubMed ID: 8460266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
    Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
    Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.
    Mills DC; Puri R; Hu CJ; Minniti C; Grana G; Freedman MD; Colman RF; Colman RW
    Arterioscler Thromb; 1992 Apr; 12(4):430-6. PubMed ID: 1558834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
    Khanna V; Armstrong PC; Warner TD; Curzen N
    Platelets; 2015; 26(7):689-92. PubMed ID: 25734957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5'-N-ethylcarboxamidoadenosine: a potent inhibitor of human platelet aggregation.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1981 Mar; 72(3):443-7. PubMed ID: 7260485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of prostaglandins E1 and E2 on thrombocyte form and aggregation].
    Antonikov IM; Alekseev OV; Chernukh AM
    Biull Eksp Biol Med; 1982 Apr; 93(4):11-3. PubMed ID: 6952942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase.
    Macfarlane DE; Mills DC; Srivastava PC
    Biochemistry; 1982 Feb; 21(3):544-9. PubMed ID: 6279146
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors influencing the response of human blood platelets to analogues of ADP which may act as partial agonists at the ADP receptor.
    Egan CM; Fisher AP; Scrutton MC
    Eur J Biochem; 1979 Mar; 95(1):127-37. PubMed ID: 110586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between the inhibition of aggregation and the concentration of cAMP in human and rat platelets.
    Michel H; Caen JP; Born GV; Miller R; D'Auriac GA; Meyer P
    Br J Haematol; 1976 May; 33(1):27-38. PubMed ID: 178342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.